Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Ravelli

Showing results (161-170 of 341) with videos related to

Pageof 35
Sort By:
Pediatric Rheumatology Online Journal|November 21, 2012
Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA studyAlessandro Consolaro, Nicolino Ruperto, Giovanni Filocamo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic ArthritisErkan Demirkaya, Stefano Lanni, Francesca Bovis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2018
Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic FeaturesGian Marco Moneta, Denise Pires Marafon, Emiliano Marasco, et al.
Clinical and Experimental Rheumatology|April 23, 2026
A novel approach to the clinical assessment of juvenile fibromyalgia syndrome: the Juvenile Fibromyalgia Multidimensional Assessment ReportEnrico Drago, Claudio Lavarello, Alessandra Alongi, et al.
Clinical and Experimental Rheumatology|March 5, 2021
Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap?Corrado Campochiaro, Alessandro Tomelleri, Elena Galli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 10, 2025
Toward a treat-to-target strategy in juvenile dermatomyositis: what are the suitable targets and optimal timing of their achievement?Jayne M MacMahon, Angelo Ravelli, Ana Isabel Rebollo-Giménez, et al.
The Lancet. Rheumatology|January 22, 2024
Artificial intelligence and high-dimensional technologies in the theragnosis of systemic lupus erythematosusKatherine Nay Yaung, Joo Guan Yeo, Pavanish Kumar, et al.
Pediatric Rheumatology Online Journal|February 26, 2025
Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinibValentina Natoli, Serena Palmeri, Ana Isabel Rebollo-Giménez, et al.
Children (Basel, Switzerland)|January 28, 2026
Non-Traumatic Clavicular Lesions in Children: Case Series and Literature ReviewFederico Diomeda, Rossella Greco, Paola Lazzari, et al.
Clinical and Experimental Rheumatology|September 12, 2013
The invisible part of the iceberg: qualitative aspects of childhood vasculitisBerna Eren Fidanci, Erkan Demirkaya, Cengizhan Acikel, et al.
Pageof 35

Showing results (161-170 of 341) with videos related to

Sort By:
Pageof 35
Pediatric Rheumatology Online Journal|November 21, 2012
Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA studyAlessandro Consolaro, Nicolino Ruperto, Giovanni Filocamo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic ArthritisErkan Demirkaya, Stefano Lanni, Francesca Bovis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2018
Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic FeaturesGian Marco Moneta, Denise Pires Marafon, Emiliano Marasco, et al.
Clinical and Experimental Rheumatology|April 23, 2026
A novel approach to the clinical assessment of juvenile fibromyalgia syndrome: the Juvenile Fibromyalgia Multidimensional Assessment ReportEnrico Drago, Claudio Lavarello, Alessandra Alongi, et al.
Clinical and Experimental Rheumatology|March 5, 2021
Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap?Corrado Campochiaro, Alessandro Tomelleri, Elena Galli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 10, 2025
Toward a treat-to-target strategy in juvenile dermatomyositis: what are the suitable targets and optimal timing of their achievement?Jayne M MacMahon, Angelo Ravelli, Ana Isabel Rebollo-Giménez, et al.
The Lancet. Rheumatology|January 22, 2024
Artificial intelligence and high-dimensional technologies in the theragnosis of systemic lupus erythematosusKatherine Nay Yaung, Joo Guan Yeo, Pavanish Kumar, et al.
Pediatric Rheumatology Online Journal|February 26, 2025
Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinibValentina Natoli, Serena Palmeri, Ana Isabel Rebollo-Giménez, et al.
Children (Basel, Switzerland)|January 28, 2026
Non-Traumatic Clavicular Lesions in Children: Case Series and Literature ReviewFederico Diomeda, Rossella Greco, Paola Lazzari, et al.
Clinical and Experimental Rheumatology|September 12, 2013
The invisible part of the iceberg: qualitative aspects of childhood vasculitisBerna Eren Fidanci, Erkan Demirkaya, Cengizhan Acikel, et al.
Pageof 35